Mihovil Spoljaric is a finance executive with extensive experience in the pharmaceutical and biotech industries. As the VP, Corporate Controller at F2G, he leverages a career built on progressive roles at companies like Nabriva Therapeutics and Elanco. He holds a Bachelor of Science from the Vienna University of Economics and Business.
His career is marked by a clear trajectory of advancement, moving from analyst positions to senior leadership, including serving as Managing Director for Nabriva Therapeutics Austrian operations. He is currently focused on expanding the finance team at F2G.